Patents by Inventor Johan Wilhelm Stjernschantz

Johan Wilhelm Stjernschantz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prostagladin derivatives for the treatment of glaucoma or ocular hypertension
    Patent number: 7163959
    Abstract: The invention relates to ophthalmological compositions for topical treatment of glaucoma or ocular hypertension comprising an effective intraocular pressure reducing amount of a prostaglandin derivative of PGA, PGB, PGD, PGE or PGF, in which the omega chain contains a ring structure, in an ophthalmologically compatible carrier. The invention further relates to the preparation of said compositions and their use for treatment of glaucoma or ocular hypertension.
    Type: Grant
    Filed: November 25, 2003
    Date of Patent: January 16, 2007
    Assignee: Pharmacia Aktiebolag
    Inventors: Johan Wilhelm Stjernschantz, Bahram Resul
  • Prostagladin derivatives for the treatment of glaucoma or ocular hypertension
    Publication number: 20040167190
    Abstract: The invention relates to ophthalmological compositions for topical treatment of glaucoma or ocular hypertension comprising an effective intraocular pressure reducing amount of a prostaglandin derivative of PGA, PGB, PGD, PGE or PGF, in which the omega chain contains a ring structure, in an ophthalmologically compatible carrier. The invention further relates to the preparation of said compositions and their use for treatment of glaucoma or ocular hypertension.
    Type: Application
    Filed: November 25, 2003
    Publication date: August 26, 2004
    Applicant: Pharmacia Aktiebolag
    Inventors: Johan Wilhelm Stjernschantz, Bahram Resul
  • Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
    Publication number: 20030181493
    Abstract: The invention relates to ophthalmological compositions for topical treatment of glaucoma or ocular hypertension comprising an effective intraocular pressure reducing amount of a prostaglandin derivative of PGA, PGB, PGD, PGE or PGF, in which the omega chain contains a ring structure, in an ophthalmologically compatible carrier. The invention further relates to the preparation of said compositions and their use for treatment of glaucoma or ocular hypertension.
    Type: Application
    Filed: December 27, 2002
    Publication date: September 25, 2003
    Inventors: Johan Wilhelm Stjernschantz, Bahram Resul
  • Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
    Publication number: 20030166729
    Abstract: The invention relates to opthalmological compositions for topical treatment of glaucoma or ocular hypertension comprising an effective intraocular pressure reducing amount of prostaglandin derivative of PGA, PGB, PGD, PGE or PGF, in which the omega chain contains a ring structure, in an opthalmologically compatible carrier. The invention further relates to the preparation of said compositions and their use for treatment of glaucoma or ocular hypertension.
    Type: Application
    Filed: November 5, 2002
    Publication date: September 4, 2003
    Inventors: Johan Wilhelm Stjernschantz, Bahram Resul
  • Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
    Publication number: 20020173525
    Abstract: The invention relates to ophthalmological compositions for topical treatment of glaucoma or ocular hypertension comprising an effective intraocular pressure reducing amount of a prostaglandin derivative of PGA, PGB, PGD, PGE or PGF, in which the omega chain contains a ring structure, in an ophthalmologically compatible carrier. The invention further relates to the preparation of said compositions and their use for treatment of glaucoma or ocular hypertension.
    Type: Application
    Filed: March 27, 2002
    Publication date: November 21, 2002
    Inventors: Johan Wilhelm Stjernschantz, Bahram Resul
  • Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
    Patent number: 6429226
    Abstract: The invention relates to ophthalmological compositions for topical treatment of glaucoma or ocular hypertension comprising an effective intraocular pressure reducing amount of a prostaglandin derivative of PGA, PGB, PGD, PGE or PGF, in which the omega chain contains a ring structure, in an ophthalmologically compatible carrier. The invention further relates to the preparation of said compositions and their use for treatment of glaucoma or ocular hypertension.
    Type: Grant
    Filed: May 1, 2000
    Date of Patent: August 6, 2002
    Assignee: Pharmacia Aktiebolag
    Inventors: Johan Wilhelm Stjernschantz, Bahram Resul
  • Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
    Patent number: 6417230
    Abstract: The invention relates to ophthalmological compositions for topical treatment of glaucoma or ocular hypertension comprising an effective intraocular pressure reducing amount of a prostaglandin derivative of PGA, PGB, PGD, PGE or PGF, in which the omega chain contains a ring structure, in an ophthalmologically compatible carrier. The invention further relates to the preparation of said compositions and their use for treatment of glaucoma or ocular hypertension.
    Type: Grant
    Filed: February 12, 2001
    Date of Patent: July 9, 2002
    Assignee: Pharmacia Aktiebolag
    Inventors: Johan Wilhelm Stjernschantz, Bahram Resul
  • Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
    Publication number: 20010014693
    Abstract: The invention relates to ophthalmological compositions for topical treatment of glaucoma or ocular hypertension comprising an effective intraocular pressure reducing amount of a prostaglandin derivative of PGA, PGB, PGD, PGE or PGF, in which the omega chain contains a ring structure, in an ophthalmologically compatible carrier. The invention further relates to the preparation of said compositions and their use for treatment of glaucoma or ocular hypertension.
    Type: Application
    Filed: February 12, 2001
    Publication date: August 16, 2001
    Inventors: Johan Wilhelm Stjernschantz, Bahram Resul
  • Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
    Patent number: 6187813
    Abstract: The invention relates to ophthalmological compositions for topical treatment of glaucoma or ocular hypertension comprising an effective intraocular pressure reducing amount of a prostaglandin derivative of PGA, PGB, PGD, PGE or PGF, in which the omega chain contains a ring structure, in an ophthalmologically compatible carrier. The invention further relates to the preparation of said compositions and their use for treatment of glaucoma or ocular hypertension.
    Type: Grant
    Filed: May 10, 1999
    Date of Patent: February 13, 2001
    Assignee: Pharmacia & Upjohn Aktiebolag
    Inventors: Johan Wilhelm Stjernschantz, Bahram Resul
  • Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
    Patent number: 6030999
    Abstract: The invention relates to ophthalmological compositions for topical treatment of glaucoma or ocular hypertension comprising an effective intraocular pressure reducing amount of a prostaglandin derivative of PGA, PGB, PGD, PGE or PGF, in which the omega chain contains a ring structure, in an ophthalmologically compatible carrier. The invention further relates to the preparation of said compositions and their use for treatment of glaucoma or ocular hypertension.
    Type: Grant
    Filed: May 10, 1999
    Date of Patent: February 29, 2000
    Assignee: Pharmacia & Upjohn Aktiebolag
    Inventors: Johan Wilhelm Stjernschantz, Bahram Resul
  • Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
    Patent number: 5849791
    Abstract: The invention relates to ophthalmological compositions for topical treatment of glaucoma or ocular hypertension comprising an effective intraocular pressure reducing amount of a prostaglandin derivative of PGA, PGB, PGD, PGE or PGF, in which the omega chain contains a ring structure, in an ophthalmologically compatible carrier. The invention further relates to the preparation of said compositions and their use for treatment of glaucoma or ocular hypertension.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: December 15, 1998
    Assignee: Pharmacia Aktiebolag
    Inventors: Johan Wilhelm Stjernschantz, Bahram Resul